According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $678.07 billion, securing the top spot among global Biotech companies. Novo Nordisk A/S (NOVO-B.CO) and Johnson & Johnson (JNJ) follow closely behind. The data was last updated on January 22, 2025.
Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
---|---|---|---|---|---|---|
601
|
Vivani Medical
VANI
|
$72.27 M | $1.22 |
3.4%
|
17.6%
|
United States
|
602
|
Ikena Oncology
IKNA
|
$70.94 M | $1.47 |
-2.0%
|
7.1%
|
United States
|
603
|
BeyondSpring
BYSI
|
$70.53 M | $1.75 |
1.8%
|
91.5%
|
United States
|
604
|
Rockwell Medical
RMTI
|
$70.45 M | $2.18 |
-1.4%
|
46.2%
|
United States
|
605
|
Context Therapeutics
CNTX
|
$70.33 M | $0.94 |
-12.2%
|
-0.98%
|
United States
|
606
|
Prenetics
PRE
|
$69.94 M | $5.72 |
3.4%
|
29.3%
|
Hong Kong
|
607
|
Burning Rock Biotech
BNR
|
$69.86 M | $6.81 |
0.46%
|
-32.7%
|
China
|
608
|
Quince Therapeutics
QNCX
|
$68.64 M | $1.56 |
-2.9%
|
30.7%
|
United States
|
609
|
PMV Pharmaceuticals
PMVP
|
$68.31 M | $1.32 |
-6.8%
|
-19.4%
|
United States
|
610
|
Oncolytics Biotech
ONCY
|
$67.83 M | $0.88 |
-13.4%
|
-31.7%
|
Canada
|
611
|
Mural Oncology
MURA
|
$67.39 M | $3.95 |
27.8%
|
-6.3%
|
Ireland
|
612
|
OptiNose
OPTN
|
$67.27 M | $6.69 |
11.6%
|
-70.0%
|
United States
|
613
|
CytomX Therapeutics
CTMX
|
$65.57 M | $0.84 |
-21.5%
|
-47.8%
|
United States
|
614
|
Immuneering
IMRX
|
$65.52 M | $2.11 |
-10.2%
|
-65.5%
|
United States
|
615
|
Mersana Therapeutics
MRSN
|
$65.16 M | $0.53 |
-61.8%
|
-80.0%
|
United States
|
616
|
Verrica Pharmaceuticals
VRCA
|
$64.87 M | $0.72 |
-1.3%
|
-88.3%
|
United States
|
617
|
Regencell Bioscience
RGC
|
$64.54 M | $4.96 |
-3.3%
|
-44.5%
|
Hong Kong
|
618
|
PepGen
PEPG
|
$64.54 M | $1.98 |
-42.9%
|
-66.6%
|
United States
|
619
|
Prelude Therapeutics
PRLD
|
$64.39 M | $1.17 |
-11.8%
|
-67.1%
|
United States
|
620
|
Generation Bio
GBIO
|
$63.83 M | $0.96 |
-11.4%
|
-49.0%
|
United States
|
621
|
iCAD
ICAD
|
$63.51 M | $2.41 |
10.7%
|
27.9%
|
United States
|
622
|
PDS Biotechnology
PDSB
|
$62.85 M | $1.68 |
-11.6%
|
-71.2%
|
United States
|
623
|
Cytosorbents
CTSO
|
$62.15 M | $1.02 |
15.3%
|
12.4%
|
United States
|
624
|
Reneo Pharmaceuticals
RPHM
|
$60.84 M | $18.20 |
0.00%
|
8.3%
|
United States
|
625
|
Werewolf Therapeutics
HOWL
|
$60.61 M | $1.36 |
-13.6%
|
-66.1%
|
United States
|
626
|
Kronos Bio
KRON
|
$60.34 M | $1.00 |
4.3%
|
-18.1%
|
United States
|
627
|
Cryo-Cell
CCEL
|
$60.22 M | $7.47 |
-4.5%
|
53.9%
|
United States
|
628
|
Tonix Pharmaceuticals
TNXP
|
$59.62 M | $0.32 |
-38.5%
|
-97.4%
|
United States
|
629
|
FibroBiologics
FBLG
|
$59.50 M | $1.69 |
-24.2%
|
-90.0%
|
United States
|
630
|
IO Biotech
IOBT
|
$59.30 M | $0.90 |
-4.2%
|
-51.8%
|
Denmark
|
631
|
Boundless Bio
BOLD
|
$57.31 M | $2.57 |
-1.9%
|
-82.2%
|
United States
|
632
|
Bioretec Oy
BRETEC.HE
|
$55.40 M | $2.37 |
1.3%
|
-1.7%
|
Finland
|
633
|
Immix Biopharma
IMMX
|
$54.47 M | $1.98 |
-6.4%
|
-56.6%
|
United States
|
634
|
Shattuck Labs
STTK
|
$53.47 M | $1.12 |
0.00%
|
-88.3%
|
United States
|
635
|
Spinnova Oyj
SPINN.HE
|
$52.82 M | $1.01 |
5.6%
|
-59.8%
|
Finland
|
636
|
Celularity
CELU
|
$52.16 M | $2.32 |
0.88%
|
-18.1%
|
United States
|
637
|
Outlook Therapeutics
OTLK
|
$52.05 M | $2.09 |
51.7%
|
-74.9%
|
United States
|
638
|
Repare Therapeutics
RPTX
|
$51.44 M | $1.21 |
-8.1%
|
-80.3%
|
Canada
|
639
|
Rafael Holdings
RFL
|
$51.22 M | $2.07 |
11.7%
|
20.4%
|
United States
|
640
|
FibroGen
FGEN
|
$50.79 M | $0.50 |
14.8%
|
-35.8%
|
United States
|
641
|
Singular Genomics Systems
OMIC
|
$50.46 M | $19.89 |
1.8%
|
62.1%
|
United States
|
642
|
MAIA Biotechnology
MAIA
|
$50.22 M | $1.92 |
0.50%
|
37.0%
|
United States
|
643
|
Fortress Biotech
FBIO
|
$49.96 M | $1.81 |
3.3%
|
-6.5%
|
United States
|
644
|
Ovid Therapeutics
OVID
|
$49.92 M | $0.70 |
-23.4%
|
-78.2%
|
United States
|
645
|
Lucid Diagnostics
LUCD
|
$48.94 M | $0.82 |
10.3%
|
-41.0%
|
United States
|
646
|
Biohit Oyj
BIOBV.HE
|
$48.69 M | $3.21 |
28.5%
|
62.4%
|
Finland
|
647
|
LakeShore Biopharma
LSB
|
$48.66 M | $2.55 |
-14.9%
|
-44.1%
|
China
|
648
|
Invivyd
IVVD
|
$48.64 M | $0.41 |
-20.4%
|
-90.9%
|
United States
|
649
|
Novacyt SA
ALNOV.PA
|
$48.38 M | $0.63 |
0.00%
|
8.2%
|
United Kingdom
|
650
|
Carmat SA
ALCAR.PA
|
$48.35 M | $1.14 |
5.2%
|
-75.4%
|
France
|
651
|
Lantern Pharma
LTRN
|
$48.32 M | $4.48 |
18.1%
|
-10.7%
|
United States
|
652
|
Spero Therapeutics
SPRO
|
$47.65 M | $0.87 |
-3.0%
|
-39.5%
|
United States
|
653
|
Amoeba SA
ALMIB.PA
|
$46.76 M | $0.94 |
3.7%
|
118.6%
|
France
|
654
|
Kezar Life Sciences
KZR
|
$46.70 M | $6.40 |
-5.6%
|
-24.5%
|
United States
|
655
|
AlloVir
ALVR
|
$46.37 M | $9.20 |
-14.9%
|
-39.8%
|
United States
|
656
|
Aileron Therapeutics
ALRN
|
$45.72 M | $1.94 |
-7.8%
|
-57.4%
|
United States
|
657
|
Serina Therapeutics
SER
|
$44.71 M | $4.76 |
-8.0%
|
-65.9%
|
United States
|
658
|
Barinthus Biotherapeutics
BRNS
|
$42.24 M | $1.05 |
2.7%
|
-62.4%
|
United Kingdom
|
659
|
NRx Pharmaceuticals
NRXP
|
$42.09 M | $3.48 |
155.4%
|
-4.5%
|
United States
|
660
|
Q32 Bio
QTTB
|
$41.90 M | $3.44 |
-0.91%
|
-69.1%
|
United States
|
661
|
Iterum Therapeutics
ITRM
|
$41.82 M | $1.52 |
-12.6%
|
-23.6%
|
Ireland
|
662
|
Actinium Pharmaceuticals
ATNM
|
$41.18 M | $1.32 |
14.8%
|
-72.8%
|
United States
|
663
|
Aspen Pharmacare
APN.JO
|
$41.17 M | $9.27 |
0.75%
|
-6.9%
|
South Africa
|
664
|
Xilio Therapeutics
XLO
|
$40.69 M | $0.89 |
-0.87%
|
86.3%
|
United States
|
665
|
SCYNEXIS
SCYX
|
$40.22 M | $1.06 |
13.1%
|
-40.4%
|
United States
|
666
|
VYNE Therapeutics
VYNE
|
$40.12 M | $2.72 |
-9.1%
|
41.4%
|
United States
|
667
|
MiNK Therapeutics
INKT
|
$40.03 M | $1.01 |
66.4%
|
-1.1%
|
United States
|
668
|
CASI Pharmaceuticals
CASI
|
$39.97 M | $2.58 |
-7.1%
|
-51.7%
|
United States
|
669
|
Atara Biotherapeutics
ATRA
|
$39.68 M | $6.89 |
-50.7%
|
-56.3%
|
United States
|
670
|
Elevation Oncology
ELEV
|
$39.61 M | $0.67 |
26.1%
|
-72.4%
|
United States
|
671
|
Tempest Therapeutics
TPST
|
$38.53 M | $0.88 |
8.1%
|
-76.6%
|
United States
|
672
|
Intensity Therapeutics
INTS
|
$38.52 M | $2.55 |
43.3%
|
-41.5%
|
United States
|
673
|
Precision BioSciences
DTIL
|
$38.13 M | $4.97 |
10.2%
|
-54.7%
|
United States
|
674
|
AN2 Therapeutics
ANTX
|
$37.65 M | $1.26 |
-6.6%
|
-93.2%
|
United States
|
675
|
Lumos Pharma
LUMO
|
$37.54 M | $4.34 |
0.00%
|
51.2%
|
United States
|
676
|
Passage Bio
PASG
|
$36.81 M | $0.60 |
-7.8%
|
-31.9%
|
United States
|
677
|
Kala Pharmaceuticals
KALA
|
$36.53 M | $7.69 |
16.2%
|
0.83%
|
United States
|
678
|
Rallybio
RLYB
|
$36.19 M | $0.87 |
2.1%
|
-36.6%
|
United States
|
679
|
Cadrenal Therapeutics
CVKD
|
$35.45 M | $19.89 |
17.8%
|
12.6%
|
United States
|
680
|
Unity Biotechnology
UBX
|
$35.22 M | $2.09 |
73.0%
|
-1.1%
|
United States
|
681
|
vTv Therapeutics
VTVT
|
$35.21 M | $13.48 |
1.3%
|
50.1%
|
United States
|
682
|
Okyo Pharma
OKYO
|
$35.06 M | $1.04 |
20.7%
|
-20.7%
|
United Kingdom
|
683
|
genOway Sa
ALGEN.PA
|
$34.79 M | $3.05 |
-20.3%
|
-30.2%
|
France
|
684
|
LianBio
LIAN
|
$34.47 M | $0.24 |
-7.5%
|
46.6%
|
United States
|
685
|
Acasti Pharma
ACST
|
$34.17 M | $3.71 |
3.1%
|
53.0%
|
Canada
|
686
|
Herantis Pharma Oyj
HRTIS.HE
|
$34.01 M | $1.69 |
8.1%
|
7.7%
|
Finland
|
687
|
Incannex Healthcare
IXHL
|
$33.26 M | $1.89 |
8.6%
|
-52.9%
|
Australia
|
688
|
Eterna Therapeutics
ERNA
|
$32.63 M | $0.64 |
68.0%
|
-75.7%
|
United States
|
689
|
Fermentalg SA
ALGAE.PA
|
$32.57 M | $0.37 |
7.3%
|
-7.2%
|
France
|
690
|
Ocuphire Pharma
OCUP
|
$31.74 M | $1.04 |
0.00%
|
-61.9%
|
United States
|
691
|
Pharma Equity Group A/S
PEG.CO
|
$30.23 M | $0.02 |
-2.8%
|
-55.3%
|
Denmark
|
692
|
Cel-Sci
CVM
|
$30.14 M | $0.41 |
-42.9%
|
-84.9%
|
United States
|
693
|
Marinus Pharmaceuticals
MRNS
|
$30.09 M | $0.55 |
110.1%
|
-94.6%
|
United States
|
694
|
CytoMed Therapeutics
GDTC
|
$29.43 M | $2.55 |
-4.3%
|
-38.7%
|
Singapore
|
695
|
BioAtla
BCAB
|
$28.93 M | $0.50 |
-20.6%
|
-74.8%
|
United States
|
696
|
iBio
IBIO
|
$28.83 M | $3.07 |
16.9%
|
162.0%
|
United States
|
697
|
Hamilton Global Opportunities Ord Shs
ALHGO.PA
|
$28.54 M | $44.56 |
-0.93%
|
-10.5%
|
United Kingdom
|
698
|
Dare Bioscience
DARE
|
$28.54 M | $3.28 |
4.4%
|
-11.9%
|
United States
|
699
|
Curis
CRIS
|
$27.69 M | $3.27 |
3.8%
|
-70.9%
|
United States
|
700
|
Aelis Farma SA
AELIS.PA
|
$27.22 M | $2.00 |
-4.0%
|
-85.8%
|
France
|
701
|
JanOne
JAN
|
$27.14 M | $2.18 |
0.00%
|
334.3%
|
United States
|
702
|
Citius Pharmaceuticals
CTXR
|
$26.68 M | $3.15 |
5.4%
|
-80.4%
|
United States
|
703
|
Advicenne S.A.
ALDVI.PA
|
$26.47 M | $2.16 |
4.0%
|
2.0%
|
France
|
704
|
Omega Therapeutics
OMGA
|
$26.30 M | $0.47 |
-34.0%
|
-84.7%
|
United States
|
705
|
Bionano Genomics
BNGO
|
$25.94 M | $0.19 |
-5.0%
|
-85.6%
|
United States
|
706
|
Longeveron
LGVN
|
$25.52 M | $1.72 |
-3.4%
|
-80.3%
|
United States
|
707
|
Sol-Gel Technologies
SLGL
|
$25.04 M | $0.90 |
-8.4%
|
-22.6%
|
Israel
|
708
|
Lava Therapeutics
LVTX
|
$24.81 M | $0.94 |
-2.6%
|
-37.9%
|
Netherlands
|
709
|
Valbiotis SA
ALVAL.PA
|
$24.13 M | $1.53 |
4.3%
|
-66.1%
|
France
|
710
|
HOOKIPA Pharma
HOOK
|
$23.99 M | $1.99 |
2.9%
|
-72.1%
|
United States
|
711
|
BioLineRx
BLRX
|
$23.47 M | $0.11 |
-52.2%
|
-92.0%
|
Israel
|
712
|
Bullfrog AI
BFRG
|
$23.18 M | $2.66 |
-0.93%
|
-69.0%
|
United States
|
713
|
Global Bioenergies SA
ALGBE.PA
|
$22.97 M | $1.06 |
20.8%
|
-48.8%
|
France
|
714
|
Renalytix
RNLX
|
$22.55 M | $0.14 |
0.00%
|
-51.5%
|
United Kingdom
|
715
|
Palatin Technologies
PTN
|
$22.52 M | $0.96 |
7.1%
|
-72.2%
|
United States
|
716
|
Equillium
EQ
|
$22.32 M | $0.63 |
-1.5%
|
-13.5%
|
United States
|
717
|
Pulmatrix
PULM
|
$22.32 M | $6.11 |
0.78%
|
220.6%
|
United States
|
718
|
Nicox S.A.
ALCOX.PA
|
$21.88 M | $0.31 |
6.4%
|
-28.1%
|
France
|
719
|
Aprea Therapeutics
APRE
|
$21.79 M | $4.01 |
22.6%
|
-31.3%
|
United States
|
720
|
Trinity Biotech
TRIB
|
$21.26 M | $0.77 |
-2.4%
|
-60.5%
|
Ireland
|
721
|
Athira Pharma
ATHA
|
$21.26 M | $0.55 |
-2.2%
|
-83.5%
|
United States
|
722
|
Senti Biosciences
SNTI
|
$20.97 M | $4.57 |
12.0%
|
5.9%
|
United States
|
723
|
Cocrystal Pharma
COCP
|
$20.35 M | $2.00 |
-21.4%
|
34.7%
|
United States
|
724
|
ImmunoPrecise Antibodies
IPA
|
$20.02 M | $0.64 |
30.9%
|
-62.1%
|
United States
|
725
|
Nfl Biosciences SAS
ALNFL.PA
|
$18.74 M | $1.95 |
1.2%
|
22.4%
|
France
|
726
|
Carisma Therapeutics
CARM
|
$18.38 M | $0.44 |
10.5%
|
-81.4%
|
United States
|
727
|
BioXcel Therapeutics
BTAI
|
$18.04 M | $0.36 |
-2.0%
|
-87.5%
|
United States
|
728
|
Affimed
AFMD
|
$18.03 M | $1.10 |
-8.1%
|
-80.4%
|
Germany
|
729
|
CervoMed
CRVO
|
$17.99 M | $2.18 |
-5.0%
|
-76.1%
|
United States
|
730
|
Pieris Pharmaceuticals
PIRS
|
$17.96 M | $13.60 |
0.00%
|
1.6%
|
United States
|
731
|
Aeterna Zentaris
AEZS
|
$17.51 M | $3.73 |
0.00%
|
-24.9%
|
United States
|
732
|
NanoViricides
NNVC
|
$17.07 M | $1.19 |
-21.2%
|
13.3%
|
United States
|
733
|
Synlogic
SYBX
|
$16.73 M | $1.43 |
5.0%
|
-54.4%
|
United States
|
734
|
GlycoMimetics
GLYC
|
$16.58 M | $0.26 |
8.3%
|
-92.6%
|
United States
|
735
|
Ocean Biomedical
OCEA
|
$16.21 M | $0.47 |
-8.5%
|
-8.5%
|
United States
|
736
|
Cingulate
CING
|
$16.16 M | $5.03 |
-2.1%
|
-88.9%
|
United States
|
737
|
Psychemedics
PMD
|
$15.74 M | $2.00 |
-0.78%
|
-40.6%
|
United States
|
738
|
Spruce Biosciences
SPRB
|
$15.59 M | $0.38 |
-7.8%
|
-85.5%
|
United States
|
739
|
Minerva Neurosciences
NERV
|
$14.76 M | $2.11 |
5.2%
|
-71.2%
|
United States
|
740
|
AIM ImmunoTech
AIM
|
$14.35 M | $0.22 |
5.0%
|
-51.2%
|
United States
|
741
|
ViroGates A/S
VIRO.CO
|
$14.14 M | $1.83 |
17.0%
|
68.8%
|
Denmark
|
742
|
Theravet SA
ALVET.PA
|
$13.74 M | $0.11 |
-14.8%
|
-93.3%
|
Belgium
|
743
|
Plant Advanced Technologies PAT SA
ALPAT.PA
|
$13.73 M | $12.29 |
0.85%
|
118.5%
|
France
|
744
|
Valerio Therapeutics SA
ALVIO.PA
|
$13.60 M | $0.09 |
16.7%
|
-34.6%
|
France
|
745
|
Imunon
IMNN
|
$12.91 M | $0.89 |
11.0%
|
54.2%
|
United States
|
746
|
Aptose Biosciences
APTO
|
$12.72 M | $0.21 |
-12.0%
|
-88.4%
|
Canada
|
747
|
Lyra Therapeutics
LYRA
|
$12.61 M | $0.19 |
11.0%
|
-96.1%
|
United States
|
748
|
ProPhase Labs
PRPH
|
$12.20 M | $0.51 |
-4.8%
|
-87.9%
|
United States
|
749
|
Talphera
TLPH
|
$12.17 M | $0.71 |
8.1%
|
-39.1%
|
United States
|
750
|
BrainStorm Cell Therapeutics
BCLI
|
$12.15 M | $2.13 |
-15.2%
|
-60.6%
|
United States
|
751
|
OpGen
OPGN
|
$12.08 M | $1.20 |
189.3%
|
-41.8%
|
United States
|
752
|
TherapeuticsMD
TXMD
|
$11.99 M | $1.04 |
-4.5%
|
-54.1%
|
United States
|
753
|
Relmada Therapeutics
RLMD
|
$11.76 M | $0.39 |
3.6%
|
-89.1%
|
United States
|
754
|
Oncodesign Precision Medicine Opm SA
ALOPM.PA
|
$11.73 M | $0.65 |
-19.5%
|
-67.5%
|
France
|
755
|
Biomerica
BMRA
|
$11.46 M | $0.62 |
128.6%
|
-34.0%
|
United States
|
756
|
Vinpai SAS
ALVIN.PA
|
$11.43 M | $3.43 |
2.8%
|
-39.6%
|
France
|
757
|
Phio Pharmaceuticals
PHIO
|
$10.94 M | $2.29 |
25.9%
|
-54.7%
|
United States
|
758
|
BLIS Technologies Ltd
BLT.NZ
|
$10.88 M | $0.01 |
0.00%
|
-16.7%
|
New Zealand
|
759
|
Ensysce Biosciences
ENSC
|
$10.80 M | $8.28 |
-22.1%
|
-62.7%
|
United States
|
760
|
Aytu BioScience
AYTU
|
$10.58 M | $1.72 |
14.7%
|
-37.5%
|
United States
|
761
|
Agile Therapeutics
AGRX
|
$10.43 M | $1.51 |
0.00%
|
4.1%
|
United States
|
762
|
bioAffinity Technologies
BIAF
|
$10.36 M | $0.67 |
-28.9%
|
-56.5%
|
United States
|
763
|
Mainz Biomed
MYNZ
|
$10.00 M | $4.50 |
1.7%
|
366.7%
|
Germany
|
764
|
AEON Biopharma
AEON
|
$9.96 M | $0.12 |
-73.5%
|
-98.2%
|
United States
|
765
|
Turnstone Biologics
TSBX
|
$9.95 M | $0.43 |
-2.9%
|
-84.8%
|
United States
|
766
|
SeaStar Medical
ICU
|
$9.90 M | $1.65 |
-13.8%
|
-91.3%
|
United States
|
767
|
Precipio
PRPO
|
$9.87 M | $6.66 |
28.9%
|
-0.46%
|
United States
|
768
|
Jaguar Health
JAGX
|
$9.81 M | $0.83 |
-18.0%
|
-85.8%
|
United States
|
769
|
Applied DNA Sciences
APDN
|
$9.77 M | $0.18 |
5.6%
|
-98.5%
|
United States
|
770
|
Eagle Pharmaceuticals
EGRX
|
$9.72 M | $0.75 |
25.0%
|
-86.3%
|
United States
|
771
|
Can Fite Biopharma
CANF
|
$9.48 M | $1.54 |
10.5%
|
-21.0%
|
Israel
|
772
|
Hoth Therapeutics
HOTH
|
$9.39 M | $1.36 |
90.6%
|
17.2%
|
United States
|
773
|
Virax Biolabs
VRAX
|
$9.29 M | $2.14 |
36.0%
|
118.7%
|
United Kingdom
|
774
|
Addex Therapeutics
ADXN
|
$8.79 M | $7.70 |
-3.8%
|
5.3%
|
Switzerland
|
775
|
Redhill Biopharma
RDHL
|
$8.44 M | $6.59 |
-0.31%
|
-71.6%
|
Israel
|
776
|
Aptorum Group
APM
|
$8.00 M | $1.12 |
28.3%
|
-34.3%
|
Hong Kong
|
777
|
Cyclerion Therapeutics
CYCN
|
$7.99 M | $2.95 |
-9.1%
|
-13.3%
|
United States
|
778
|
Biofrontera
BFRI
|
$7.90 M | $1.02 |
8.9%
|
-33.7%
|
United States
|
779
|
Mangoceuticals
MGRX
|
$7.53 M | $3.03 |
3.6%
|
-42.8%
|
United States
|
780
|
TME Pharma NV
ALTME.PA
|
$7.30 M | $0.08 |
3.9%
|
-64.3%
|
Germany
|
781
|
Arcadia Biosciences
RKDA
|
$7.10 M | $5.20 |
-18.9%
|
103.7%
|
United States
|
782
|
Orphazyme A/S
ORPHA.CO
|
$6.52 M | $156.28 |
0.00%
|
-12.7%
|
Denmark
|
783
|
Xenetic Biosciences
XBIO
|
$6.66 M | $4.32 |
2.2%
|
20.8%
|
United States
|
784
|
Viracta Therapeutics
VIRX
|
$6.48 M | $0.16 |
-32.0%
|
-65.3%
|
United States
|
785
|
BioNexus Gene Lab
BGLC
|
$6.43 M | $0.36 |
52.3%
|
-31.9%
|
Malaysia
|
786
|
Evoke Pharma
EVOK
|
$6.39 M | $4.30 |
-10.2%
|
-41.8%
|
United States
|
787
|
Adial Pharmaceuticals
ADIL
|
$6.24 M | $0.96 |
-8.6%
|
-24.4%
|
United States
|
788
|
Eyenovia
EYEN
|
$6.18 M | $0.06 |
-26.7%
|
-96.2%
|
United States
|
789
|
Soligenix
SNGX
|
$6.17 M | $2.46 |
-17.8%
|
-76.3%
|
United States
|
790
|
Syros Pharmaceuticals
SYRS
|
$5.51 M | $0.21 |
7.9%
|
-96.6%
|
United States
|
791
|
Organovo
ONVO
|
$5.49 M | $0.36 |
14.7%
|
-61.8%
|
United States
|
792
|
Nuwellis
NUWE
|
$5.42 M | $1.24 |
11.0%
|
-94.0%
|
United States
|
793
|
AVROBIO
AVRO
|
$5.24 M | $1.40 |
0.00%
|
-100.0%
|
United States
|
794
|
Bionomics
BNOX
|
$4.95 M | $3.24 |
-51.1%
|
-72.3%
|
Australia
|
795
|
Quoin Pharmaceuticals
QNRX
|
$4.83 M | $0.59 |
17.7%
|
-85.4%
|
United States
|
796
|
Galmed Pharmaceuticals
GLMD
|
$4.72 M | $2.85 |
-5.6%
|
-36.7%
|
Israel
|
797
|
180 Life Sciences
ATNF
|
$4.67 M | $1.47 |
-46.2%
|
-61.1%
|
United States
|
798
|
Portage Biotech
PRTG
|
$4.60 M | $4.10 |
-20.8%
|
-80.2%
|
|
799
|
Theranexus SA
ALTHX.PA
|
$4.58 M | $0.57 |
-3.5%
|
-44.9%
|
France
|
800
|
Instituto Rosenbusch S.A.
ROSE.BA
|
$4.39 M | $0.10 |
-6.3%
|
31.2%
|
Argentina
|